Effects of allergic dermatosis on health-related quality of life.

被引:45
作者
Anderson R.T. [1 ]
Rajagopalan R. [1 ]
机构
[1] Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, 27157, NC
关键词
Atopic Dermatitis; Skin Disease; Urticaria; Contact Dermatitis; Allergic Contact Dermatitis;
D O I
10.1007/s11882-001-0041-3
中图分类号
学科分类号
摘要
Allergic dermatosis is a class of immunologic skin diseases manifested as intense itching, which potentially leads to a cycle of skin pain, damage, and infection. Information collected from clinical samples on health-related quality of life shows that some individuals may suffer from poor-quality sleep, physical and emotional distress, and limitations in social functioning. Although many individual factors may moderate the impact of disease on quality of life, disease severity is consistently linked to amount of limitation. There are only sparse data from population surveys in which participants are not selected based on willingness to join a treatment trial for relief of symptoms. This article presents quality-of-life and disease burden data on 559 persons in a community survey who reported signs and symptoms consistent with allergic dermatosis. Quality of life was assessed using the Dermatology-specific Quality of Life (DSQL) questionnaire. Overall, greater disease severity was associated with higher DSQL scores. Noticeable deficits were reported among those who rated their disease as moderate or severe, especially in terms of physical discomfort, sleep disturbance, and negative self-perceptions and emotions. These complaints correlated significantly with out-of-pocket expenses for lotions and emollients to control skin disease. Despite these complaints, the median number of days from the last primary healthcare visit was 453 days, indicating that many dermatosis sufferers are not accessing expert medical care that could alleviate distress.
引用
收藏
页码:309 / 315
页数:6
相关论文
共 41 条
  • [1] Berzon R(1993)International use, application and performance of health-related quality of life instruments Qual Life Res 2 367-368
  • [2] Hays RD(1997)The impact of chronic urticaria on the quality of life Br J Dermatol 136 197-201
  • [3] Shumaker SA(1996)Cyclosporin in severe childhood dermatitis: a multicenter study J Am Acad Dermatol 34 1016-1021
  • [4] O’Donnell BF(1993)Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial Br J Dermatol 129 422-430
  • [5] Lawlor F(1996)Measurement of disease activity and outcome in atopic dermatitis Br J Dermatol 135 509-515
  • [6] Simpson J(1978)The effect of skin disease on self image Br J Dermatol 99 18-19
  • [7] Berth-Jones J(1999)An assessment of anxiety and dermatology life quality in patients with atopic dermatitis Br J Dermatol 140 268-272
  • [8] Finlay AY(1990)Measurement of atopic dermatitis disability Ann Dermatol 2 9-12
  • [9] Zaki I(2000)A body-weightindependent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life J Am Acad Dermatol 42 653-659
  • [10] Salek MS(1995)Chronic urticaria N Engl J Med 332 1767-1772